Zobrazeno 1 - 10
of 11
pro vyhledávání: '"William J. Cady"'
Publikováno v:
JAMA: The Journal of the American Medical Association. 264:972
In Reply.— We appreciate the opportunity to respond to the comments of Cappuccio et al. The measurement of blood pressure at 12 ± 2 hours after receiving a dose was not an SD but a commonly used protocol requirement that all blood pressure measure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d47d0325f52b2c580d1c160723ceb980
https://doi.org/10.1001/jama.1990.03450080057024
https://doi.org/10.1001/jama.1990.03450080057024
Autor:
Suzanne Oparil, William J. Cady, Michael A. Weber, William H. Stewart, Matthew R. Weir, James F. Burris
Publikováno v:
JAMA. 263:1507
This multicenter, factorial-design trial assessed the safety and additive antihypertensive efficacy of a slow-release (SR) formulation of diltiazem hydrochloride given alone or in combination with hydrochlorothiazide for treatment of mild to moderate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbf626b88bb704540f5344ec1d7b5e63
https://doi.org/10.1001/jama.1990.03440110073031
https://doi.org/10.1001/jama.1990.03440110073031
Autor:
William J. Cady
Publikováno v:
Clinical Research Practices and Drug Regulatory Affairs. 3:295-306
Federal regulations govern all areas of both preclinical and clinical research. These rules, proposed and currently enacted, serve to provide guidelines to the investigator for the proper conduct and ultimate acceptance by the federal agencies. It is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dccb428dfa047afbe2ba13119c7da2b3
https://doi.org/10.3109/10601338509051222
https://doi.org/10.3109/10601338509051222
Autor:
R Michael Rubison, Richard L. Byyny, William J Cady, Alan S Nies, Patrick J Bryant, Robert W Piepho, Vaughn L Culbertson
Publikováno v:
Clinical Pharmacology and Therapeutics. 39:690-696
In a randomized, double-blind, dose-ranging trial, the acute antihypertensive effects of 7.5, 15, 30, 45, 60, 90, and 120 mg single daily doses of urapidil were compared with those of placebo in 10 patients with essential hypertension. Patients were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4feec4c1d807e225e6f7dd2f048fe58a
https://doi.org/10.1038/clpt.1986.120
https://doi.org/10.1038/clpt.1986.120
Publikováno v:
American Journal of Health-System Pharmacy. 36:92-95
Two case reports describing the treatment of digitoxin toxicity with cholestyramine resin are presented. Both female patients were receiving 100 microgram/day of digitoxin when toxicity occurred. In both patients, digitoxin was discontinued and hypok
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe48a67a23ab7a685194d4cdd1e98ffe
https://doi.org/10.1093/ajhp/36.1.92
https://doi.org/10.1093/ajhp/36.1.92
Autor:
Ward A. Chambers, Charles S. Wilson, Terry L. Holcslaw, Alan D. Forker, Richard R. Miles, William J. Cady
Publikováno v:
American Heart Journal. 99:181-184
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d9f3d4f50575fdf8617073f33dbb464
https://doi.org/10.1016/0002-8703(80)90763-2
https://doi.org/10.1016/0002-8703(80)90763-2
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 17:645-648
Total joint arthroplasty is a common orthopedic procedure and requires prophylactic antibiotic coverage to prevent infections in the operated joint. The antibiotics routinely used for prophylaxis are the cephalosporins. This study compared bone, syno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd9ecb761ccfbe8047a4485b00fb572
https://doi.org/10.1177/106002808301700910
https://doi.org/10.1177/106002808301700910
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 11:462-464
Three case reports indicate that infants below 10 kg in weight require greater mg/kg doses of phenytoin than larger infants or adults in order to achieve therapeutic plasma levels between 10–20 mcg/ml. In the absence of access to plasma phenytoin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3861e12039b2c743f500bd0e4f812cf
https://doi.org/10.1177/106002807701100802
https://doi.org/10.1177/106002807701100802
Publikováno v:
Toxicology letters. 7(4-5)
Male rats were treated with either adriamycin (2 mg/kg, i.v. weekly) or adriamycin and tetracycline (10 mg/kg, i.p., daily) for 8 weeks. Serum creatine phosphokinase (CPK) activity was measured after 8 weeks as an index of cardiotoxicity. Serum CPK w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c2c2adb7cfdf9bf22d8f9006233abe2
https://pubmed.ncbi.nlm.nih.gov/7222116
https://pubmed.ncbi.nlm.nih.gov/7222116
Autor:
William J. Cady, H.B. Kostenbauder, John Hackman, Byron Young, Robert P. Rapp, Donald G. Perrier, Salvador Pancorbo
Publikováno v:
Annals of internal medicine. 85(3)
A parenteral dosing regimen was designed for the immediate attainment and maintenance of therapeutic plasma levels of phenytoin in patients requiring anticonvulsant therapy, but not able to tolerate oral medication. An intravenous dose of 10.7 mg/kg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e24121eaf20a1ebf5f14a4346a08ee83
https://pubmed.ncbi.nlm.nih.gov/822764
https://pubmed.ncbi.nlm.nih.gov/822764